Laval study finds 79% of Canadians support therapeutic use of psilocybin at end of life
Nearly four out of five Canadians believe the use of psilocybin is an acceptable medical approach to treat existential distress in patients suffering from a serious and incurable disease. Support for psilocybin is higher among respondents who were